. 2008 May 1;9(2):225–240. doi: 10.1007/s10162-008-0119-x

TABLE 1.

Surviving ESCs 3–4 weeks after transplant

Model	Animal ID	Injection site(s)	Cell type injected	Mean number of surviving ESCs per section (n = 5)
EPI	RS472	RC, PLS	D3/bcl2	13
EPI	RS473^a	RC, PLS	D3/bcl2	196^b
EPI	RS477^a	RC, PLS	D3/bcl2	90^b
EPI	RS480^a	RC, PLS	D3/EGFP	199^b
EPI	RS481^a	RC, PLS	D3/EGFP	74^b
EPI	RS482^a	RC, PLS	D3	15
EPI	RS485^a	RC, PLS	D3/bcl2	213^b
EPI	RS486^a	RC, PLS	D3/EGFP	40
EPI	RS487	RC, PLS	D3/EGFP	26
EPI	RS488^a	RC, PLS	D3	47
EPI	RS494	RC, PLS	D3/bcl2	30
EPI	RS501	RC, PLS	D3	65
EPI	RS440	PLS	D3/EGFP	0
EPI	RS468	PLS	D3/EGFP	12
EPI	RS474^a	PLS	D3/bcl2	11
EPI	RS476^a	PLS	D3/bcl2	63^b
EPI	RS478^a	PLS	D3/bcl2	86
EPI	RS479^a	PLS	D3/bcl2	10
EPI	RS484	PLS	D3/bcl2	23
EPI	RS490	PLS	D3	0
EPI	RS491	PLS	D3	0
EPI	RS495	PLS	D3/bcl2	56
EPI	RS499^a	PLS	D3	63
LPI	RS454	RC, PLS	D3/bcl2	7
LPI	RS456	RC, PLS	D3/bcl2	3
LPI	RS457	RC, PLS	D3/bcl2	3
LPI	RS469	RC, PLS	D3/EGFP	6
LPI	RS471^a	RC, PLS	D3/bcl2	53
LPI	RS483	RC, PLS	D3/EGFP	0
LPI	RS493	RC, PLS	D3/bcl2	0
LPI	RS437	PLS	D3	11
LPI	RS441^a	PLS	D3	3
LPI	RS442	PLS	D3	0
LPI	RS455^a	PLS	D3/bcl2	37
LPI	RS458	PLS	D3/bcl2	1
LPI	RS465	PLS	D3/EGFP	0
LPI	RS470	PLS	D3/bcl2	0
LPI	RS492	PLS	D3/bcl2	9
Normal	RS489	PLS	D3	6
Normal	RS496	PLS	D3/bcl2	0
Normal	RS497	PLS	D3/bcl2	0

Early post-injury (EPI) and late post-injury (LPI) gerbils received ESCs within 1–3 days and 1–4 weeks after ouabain treatment, respectively

ELS endolymphatic space, PLS perilymphatic space, RC, Rosenthal’s canal

^aThese ears were processed for immunostaining for NF-200 and/or GFAP.

^bThe vascular remodeling was present in surviving ESC masses.